CRIS Current Research Information System

TEDESCHI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.350
EU - Europa 2.483
AS - Asia 1.053
AF - Africa 149
SA - Sud America 18
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.064
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.342
IT - Italia 654
GB - Regno Unito 504
SE - Svezia 416
CN - Cina 374
SG - Singapore 278
DE - Germania 277
VN - Vietnam 170
IN - India 140
IE - Irlanda 125
RU - Federazione Russa 84
FR - Francia 81
BG - Bulgaria 76
CH - Svizzera 50
CI - Costa d'Avorio 43
ZA - Sudafrica 38
ES - Italia 37
TG - Togo 37
EE - Estonia 36
JO - Giordania 35
UA - Ucraina 31
BE - Belgio 30
FI - Finlandia 24
NG - Nigeria 24
NL - Olanda 14
AT - Austria 9
AU - Australia 9
KR - Corea 9
RO - Romania 9
BR - Brasile 8
CA - Canada 7
GR - Grecia 6
IR - Iran 6
JP - Giappone 6
AE - Emirati Arabi Uniti 4
HR - Croazia 4
PH - Filippine 4
PK - Pakistan 4
AR - Argentina 3
BD - Bangladesh 3
CZ - Repubblica Ceca 3
PL - Polonia 3
PT - Portogallo 3
TH - Thailandia 3
TN - Tunisia 3
TR - Turchia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
EC - Ecuador 2
ID - Indonesia 2
IL - Israele 2
LB - Libano 2
LY - Libia 2
MY - Malesia 2
PE - Perù 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AZ - Azerbaigian 1
BZ - Belize 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
FK - Isole Falkland (Malvinas) 1
HK - Hong Kong 1
HU - Ungheria 1
MA - Marocco 1
MD - Moldavia 1
MN - Mongolia 1
NO - Norvegia 1
SN - Senegal 1
UZ - Uzbekistan 1
Totale 7.064
Salva come PNG Salva come JPEG
Città #
Southend 457
Fairfield 436
Chandler 333
Ashburn 283
Singapore 243
Wilmington 200
Woodbridge 198
Ann Arbor 193
Seattle 162
Houston 160
Cambridge 147
Bologna 146
Princeton 131
Dublin 125
Dong Ket 101
New York 87
Sofia 72
Milan 48
Abidjan 43
Nanjing 43
Westminster 43
Berlin 39
Bern 39
Lomé 37
Saint Petersburg 36
Amman 35
Beijing 34
Padova 34
San Diego 30
Bremen 29
Jinan 29
Redmond 28
Brussels 27
Falls Church 27
Santa Clara 26
Turin 26
Rome 24
Abeokuta 22
Helsinki 21
Shenyang 20
Chicago 18
Redwood City 18
Hebei 17
Washington 17
Nanchang 16
Boardman 15
Dearborn 15
Florence 15
Parma 15
Des Moines 14
Zhengzhou 12
Changsha 11
Olalla 11
Leganés 10
Bühl 9
Los Angeles 9
Ningbo 9
Reggio Emilia 9
Vicenza 9
Brescia 8
Guangzhou 8
Naples 8
Norwalk 8
São Paulo 8
Verona 8
Vienna 8
Amsterdam 7
Jiaxing 7
London 7
Mülheim 7
Shanghai 7
Taizhou 7
Tianjin 7
Fuzhou 6
Leawood 6
Mountain View 6
Shenzhen 6
Taiyuan 6
Costa Mesa 5
Haikou 5
Hangzhou 5
Incheon 5
Lanzhou 5
Marratxí 5
Modena 5
Paris 5
Pavia 5
Pisa 5
San Francisco 5
Sydney 5
Tampa 5
Venezia 5
Duncan 4
Hefei 4
Jacksonville 4
Lunano 4
Noventa di Piave 4
Torino 4
Toronto 4
Trieste 4
Totale 4.700
Salva come PNG Salva come JPEG
Nome #
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 175
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 174
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 165
An Antimicrobial Stewardship Program Based on Systematic Infectious Disease Consultation in a Rehabilitation Facility 151
Infectious diseases team for the early management of severe sepsis and septic shock in the emergency department 143
Impact on mortality of a bundle for the management of enterococcal bloodstream infection 132
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 131
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 131
Superficial swab versus deep-tissue biopsy for the microbiological diagnosis of local infection in advanced-stage pressure ulcers of spinal-cord-injured patients: a prospective study 130
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. 130
Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 128
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 127
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy 126
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 126
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment 126
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 118
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 116
Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy 115
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment 114
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre 114
Outcome of hepatocellular carcinoma in human immunodeficiency virus-infected patients. 113
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study 113
Clinical impact of reninangiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for coronavirus disease 2019 111
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. 110
Predictive models for identification of hospitalized patients harboring KPC-producing klebsiella pneumoniae 110
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors 106
The burden of colonization and infection by carbapenemase-producing Enterobacteriaceae in the neuro-rehabilitation setting: A prospective six-year experience 104
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy 103
Treatment of MDR-Gram negative infections in the 21st century: a never ending threat for clinicians 101
Use of Daptomycin in Critically Ill Children with Bloodstream Infections and Complicated Skin and Soft-tissue Infections 101
Population pharmacokinetics and Monte Carlo simulation for dosage optimization of fosfomycin in the treatment of osteoarticular infections in patients without renal dysfunction 100
Clinical experience with dalbavancin for the treatment of deep sternal wound infection 99
Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae 98
Tenofovir-induced renal toxicity in 324 HIV-infected, antiretroviral-naive patients. 97
Prevention of infections in nursing homes: Antibiotic prophylaxis versus infection control and antimicrobial stewardship measures 97
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients 95
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 94
Opportunistic infections in end stage liver disease 94
Multidrug-Resistant Bacterial Infections in Solid Organ Transplant Candidates and Recipients 94
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study 92
null 91
null 90
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 89
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 88
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 87
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia 86
Reply: Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 86
Population pharmacokinetics of dalbavancin and dosing consideration for optimal treatment of adult patients with staphylococcal osteoarticular infections 86
The role of extended infusion β-lactams in the treatment of bloodstream infections in patients with liver cirrhosis 85
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 84
[Prospective multicentre survey on clinical features and management approach to community-acquired pneumonia in emergency departments in Italy: focus on hospital admitted cases] 81
null 77
null 76
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 76
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case-control-control study 75
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study 75
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study 71
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort 65
Bone and Joint Infections: The Role of Imaging in Tailoring Diagnosis to Improve Patients' Care 64
A descriptive case series of the relationship between maintenance of conservative PK/PD efficacy thresholds of dalbavancin over time and clinical outcome in long-term treatment of staphylococcal osteoarticular infections 63
Individualizing duration of antibiotic therapy in community-acquired pneumonia 61
null 56
Usefulness of therapeutic drug monitoring in estimating the duration of dalbavancin optimal target attainment in staphylococcal osteoarticular infections: a proof-of-concept 54
Effective Containment of a COVID-19 Subregional Outbreak in Italy through Strict Quarantine and Rearrangement of Local Health Care Services 54
Quality of care indicators in the MAnageMent of BlOOdstream infections caused by Enterobacteriaceae (MAMBOO-E study): state of the art and research agenda 50
Reply to Baklouti et al., "Why Is It Desirable To Do the External Evaluation of a Population Pharmacokinetic Model?" 46
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study 45
Pharmacokinetic and pharmacodynamic considerations for optimizing antimicrobial therapy used to treat bone and joint infections: an evidence-based algorithmic approach 43
Multidisciplinary treatment protocol for ischiatic, sacral, trochanteric or other pressure injuries in people with spinal cord injury: a retrospective cohort study 40
Treatment duration for central line-associated infection caused by Enterococcus spp.: a retrospective evaluation of a multicenter cohort 38
A Proof of Concept of the Usefulness of a TDM-Guided Strategy for Optimizing Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Ampicillin-Based Regimens in a Case Series of Patients with Enterococcal Bloodstream Infections and/or Endocarditis 38
Oral Versus Standard Antimicrobial Treatment for Pyogenic Native Vertebral Osteomyelitis: A Single-Center, Retrospective, Propensity Score-Balanced Analysis 37
The efficacy of suppressive antibiotic treatment in patients managed non-operatively for periprosthetic joint infection and a draining sinus 37
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: An observational multicenter study 36
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients 36
Combined Orthoplastic Approach in Fracture-Related Infections of the Distal Tibia 32
Treatment duration for Escherichia coli bloodstream infection and outcomes: Retrospective single-centre study 30
Multiple Flaps for Trochanteric Pressure Sore Reconstruction: A Case Series 27
Osteomyelitis of the pelvic bones in patients with spinal cord injury: Is magnetic resonance useful for preoperative diagnosis? 27
Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae 27
Implementation and validation of a Bayesian method for accurately forecasting duration of optimal pharmacodynamic target attainment with dalbavancin during long-term use for treating subacute and/or chronic staphylococcal infections 26
Interindividual and intra-individual variabilities of darunavir and ritonavir plasma trough concentrations in multidrug experienced hiv patients receiving salvage regimens 26
Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort 25
Population Pharmacokinetic and Pharmacodynamic Analysis of Dalbavancin for Long-Term Treatment of Subacute and/or Chronic Infectious Diseases: The Major Role of Therapeutic Drug Monitoring 24
"MRI, culture of swab specimen and two stage surgery in spinal cord injury patients with pressure sores" 20
Obesity Is One of the Strongest Risk Factor for Respiratory Failure and Death in COVID-19 Patients: A Retrospective Multicentric Cohort Study 19
Rates and Predictors of Treatment Failure in Staphylococcus aureus Prosthetic Joint Infections According to Different Management Strategies: A Multinational Cohort Study-The ARTHR-IS Study Group 18
Silver-Coated Distal Femur Megaprosthesis in Chronic Infections with Severe Bone Loss: A Multicentre Case Series 16
Population Pharmacokinetics and Pharmacodynamics of Dalbavancin and C-Reactive Protein in Patients with Staphylococcal Osteoarticular Infections 12
Community use of antibiotics during the COVID-19 lockdown 11
Incidence, associated disease burden and healthcare utilization due to Staphylococcus aureus prosthetic joint infection in European hospitals: the COMBACTE-NET ARTHR-IS multi-centre study 9
Preoperative and perioperative risk factors, and risk score development for prosthetic joint infection due to Staphylococcus aureus: a multinational matched case-control study 7
Totale 7.326
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.410
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.410
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.171 0 0 0 72 142 145 183 218 203 90 49 69
2020/2021936 135 57 21 29 93 46 12 63 92 77 55 256
2021/20221.413 61 56 65 144 121 77 80 106 77 162 261 203
2022/20231.638 126 184 89 225 149 121 61 114 298 69 116 86
2023/2024907 71 91 55 106 78 198 63 58 33 72 36 46
2024/2025687 115 251 217 104 0 0 0 0 0 0 0 0
Totale 7.326